Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: A double-blind, randomized parallel evaluation-Reference-Cited by-同舟云学术

Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: A double-blind, randomized parallel evaluation

Published:1995-01 Issue:1 Volume:129 Page:87-97
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Singh Bramah N.,Kehoe Richard,Woosley R.L.,Scheinman Melvin,Quart Barry

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference49 articles.

1. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists;Lish;J Pharmacol Exp Ther,1965

2. New perspectives in the pharmacologic therapy of cardiac arrhythmias;Singh;Prog Cardiovasc Dis,1980

3. A third class of antiarrhythmic action: effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle of MJ1999 and AH 3676;Singh;Br J Pharmacol,1970

4. Comparative mechanisms of action of antiarrhythmic drugs;Singh;Am Heart J,1974

5. Electrophysiologic testing of therapy with sotalol for sustained ventricular tachycardia;Senges;Circulation,1984

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

2. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

3. Association of sotalol versus atenolol therapy with survival in dogs with severe subaortic stenosis;Journal of Veterinary Cardiology;2023-08

4. Statistical learning in preclinical drug proarrhythmic assessment;Journal of Biopharmaceutical Statistics;2022-05-04

5. Antiarrhythmic agents and torsades de pointes;Torsades de Pointes;2022